One French firm is leading the way in developing a radical new approach to food allergy treatment – you can find out more on http://www.dbv-technologies.com/en/. DBV-Technologies has been investigating ways of safely diagnosing and treating some of our more common allergies, with the emphasis being firmly laid on patient safety. Other frequently adopted food allergy treatment methods may put patients with very high intolerances to certain foodstuffs at risk of anaphylactic shock.
This is a worry as far as immunotherapy through the administration of antigens by injection is concerned. However, DBV-Technologies’ peanut allergy treatment , just like its cows’ milk protein and house dust mite versions, is much safer than traditional methods. This is because it introduces allergens to the body via the skin, to be more precise, through the Langerhans cells. As a result, the antigens do not enter the bloodstream directly – which is the main Achille’s Heel of the injection approach.
With headquarters in the Greater Paris area (see below), DBV-Technologies has brought together a highly-qualified team and state of the art technology and equipment that it hopes will enable it to offer a truly groundbreaking solution to this issue.